Clinicopathological features and Borrmann classification associated with HER2-positive in primary gastric cancer

PURPOSE: Human epidermal growth factor receptor 2 (HER2) assesment is important for patients with advanced gastric cancer (GC) to determine trastuzumab therapy is being considered. A study was performed to evaluate the rate of HER2 positivity in patients with primary gastric cancer and to assess the...

Descripción completa

Detalles Bibliográficos
Autores principales: Dai, Xiaomin, Zhang, Xijiong, Yu, Jin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6605773/
https://www.ncbi.nlm.nih.gov/pubmed/31303779
http://dx.doi.org/10.2147/CEG.S212895

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6605773/
https://www.ncbi.nlm.nih.gov/pubmed/31303779
http://dx.doi.org/10.2147/CEG.S212895

Ejemplares similares